Congress Asset Management’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-45,836
| Closed | -$1.84M | – | 371 |
|
|
2024
Q1 | $1.84M | Buy |
45,836
+533
| +1% | +$21.4K | 0.01% | 278 |
|
|
2023
Q4 | $1.15M | Buy |
45,303
+117
| +0.3% | +$2.98K | 0.01% | 311 |
|
|
2023
Q3 | $628K | Buy |
45,186
+61
| +0.1% | +$848 | 0.01% | 330 |
|
|
2023
Q2 | $1.04M | Buy |
45,125
+556
| +1% | +$12.8K | 0.01% | 307 |
|
|
2023
Q1 | $1.32M | Buy |
+44,569
| New | +$1.32M | 0.01% | 297 |
|